TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02442232 — Predictive Biomarker (PRD): PRKCA mRNA
Genes: PRKCA; PKCA; PRKACA
Study NCT02442232 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02065362 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study NCT05093179 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01710852 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04203914 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04203914 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04490889 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00673595 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002681 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01335464 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01674842 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04919915 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03553030 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT02978222 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02978222 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT04713943 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01128205 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03476044 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00459056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03216928 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03216928 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT05513118 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02553837 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04290637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03523442 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01931046 — Predictive Biomarker (PRD): DKK3 mRNA
Genes: DKK3; REIC; UNQ258/PRO295
Study NCT04355728 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03829800 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02420782 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT01030601 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01030601 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03374150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00889785 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00388427 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00764725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01636557 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01636557 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01636557 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01636557 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04318145 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03551925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04637867 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01847807 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02658461 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02048904 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02048904 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06071611 — Predictive Biomarker (PRD): TPSG1 mRNA
Genes: TPSG1; PRSS31; TMT
Study NCT06071611 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00354302 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00706732 — Surrogate Endpoint (SUR): Serum antibody concentration
Study NCT03292133 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00162955 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT00873678 — Predictive Biomarker (PRD): AHI1 mRNA
Genes: AHI1
Study NCT00873678 — Predictive Biomarker (PRD): NPHP1 mRNA
Genes: NPHP1; NPH1
Study NCT00873678 — Predictive Biomarker (PRD): CEP290 mRNA
Genes: CEP290; BBS14; KIAA0373; NPHP6
Study NCT04277442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01191450 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01537120 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02691689 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02479243 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT01042262 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00318175 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00629278 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02341612 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT00836940 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02974244 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00445809 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02812706 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT00764855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01656642 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01173887 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT00004483 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT04384341 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01778725 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT00453037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04610619 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT02876978 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT00284570 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01624129 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study NCT01848275 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02141464 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03626090 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02920229 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04104269 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00925743 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02772198 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01419821 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01419821 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04256213 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT00593580 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01089361 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04253509 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04493164 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT00278915 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study NCT04128696 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT03809624 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04173793 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01935531 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03906825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02299193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04217343 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04217343 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT04217343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04217343 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03473457 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03473457 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT03473457 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT00817479 — Predictive Biomarker (PRD): SGK1 mRNA
Genes: SGK1; SGK
Study NCT00817479 — Predictive Biomarker (PRD): DUSP1 mRNA
Genes: DUSP1; CL100; MKP1; PTPN10; VH1
Study NCT03887117 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02616679 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02616679 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04292977 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01824797 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00591253 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03871907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03871907 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01922921 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02354833 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01548261 — Predictive Biomarker (PRD): TP63 mRNA
Genes: TP63; KET; P63; P73H; P73L; TP73L
Study NCT04085159 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT04039165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04363736 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00496366 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01468649 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT04450810 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT03923803 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01653379 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00251771 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT04590248 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT03673904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01771783 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01771783 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00310453 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00868387 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01265654 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04540796 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT00133653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03156517 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT01401998 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT02063529 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02063529 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00649311 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04528901 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04582097 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04284631 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01026688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00246571 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00246571 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04396977 — Pharmacodynamic Biomarker (PDY): Dermal blood flow
Study NCT04466124 — Predictive Biomarker (PRD); Safety Biomarker (SAF): GSTP1
Genes: GSTP
Study NCT04466124 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04466124 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04466124 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study NCT04466124 — Predictive Biomarker (PRD): TOP2A mRNA
Genes: TOP2A; TOP2
Study NCT04466124 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT04666207 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03197805 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00162903 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03567187 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study NCT00310310 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01335022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02100852 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04271267 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01830530 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00644592 — Predictive Biomarker (PRD): NR1H3 mRNA
Genes: NR1H3; LXRA
Study NCT00828451 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04006847 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04006847 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00969657 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04177303 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00066807 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02588378 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT02588378 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02612350 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02612350 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04520477 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT03822910 — Predictive Biomarker (PRD): CA3 mRNA
Genes: CA3
Study NCT03822910 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1
Study NCT05080361 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT05066685 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01015911 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT00689442 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT02625922 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT03255070 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00815646 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01548144 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02625168 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01020487 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study NCT01020487 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00475423 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01926886 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02869295 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT03770000 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01492543 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01331018 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT00991952 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01520246 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT01520246 — Predictive Biomarker (PRD): PDLIM2 mRNA
Genes: PDLIM2; PP6345
Study NCT00005383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01232374 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01232374 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02634710 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT00201812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03435978 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03256890 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03637673 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT01452113 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03676959 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01436019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00444015 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT00444015 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03754985 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01626157 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03322358 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00881543 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00838500 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02057328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01227824 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT02812888 — Predictive Biomarker (PRD): ANGPTL8 mRNA
Genes: ANGPTL8; C19orf80; RIFL; UNQ599/PRO1185
Study NCT02812888 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01247298 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT03053908 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01829126 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01580735 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02492737 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT02492737 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT00840359 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT01773278 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT04564924 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04407169 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00294710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03549884 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT03549884 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03549884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04417387 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT04444284 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03605953 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04792294 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03189381 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01682044 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00963807 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00524173 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00524173 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02947373 — Predictive Biomarker (PRD): PNOC mRNA
Genes: PNOC; OFQ
Study NCT02338986 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02021994 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02046473 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00982722 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03434821 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT03303391 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03429218 — Predictive Biomarker (PRD): ACRV1 mRNA
Genes: ACRV1
Study NCT02632838 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00943943 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00943943 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01401478 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01435499 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01435499 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT04032275 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04426760 — Predictive Biomarker (PRD): HOXA10 mRNA
Genes: HOXA10; HOX1H
Study NCT06246227 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02244164 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02948894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02948894 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03282747 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT01810809 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00274144 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02174900 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT06191510 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06191510 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT06191510 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03358680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01517880 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study NCT01606878 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK